| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |